Lisa A. Beck, MD, FAAD
Dept of Dermatology, University of Rochester Medicine, Rochester, NY
Lisa A. Beck, MD, FAAD is listed at Dept of Dermatology, University of Rochester Medicine, Rochester, NY. Lisa is scheduled to speak at American Academy of Dermatology Annual Meeting 2027 on 21 March 2027.
Compiled from published conference agendas; not yet confirmed by Lisa. Is this you? Claim this profile.
About
Dr. Lisa A. Beck is an internationally recognized expert in atopic dermatitis (AD), whose research focuses on epithelial abnormalities in AD focusing on their import in allergen sensitization, barrier dysfuction and cutaneous infections. She and Dr. De Benedetto were the first to characterize epidermal tight junction defects in AD. She played a pivotal role in the clinical development of dupilumab (Dupixent), the first biologic approved for moderate-to-severe AD; and was the lead author of the 2014 New England Journal of Medicine publication that helped establish the foundation for FDA approval in 2017. Continuously funded by the NIH since 1994, Dr. Beck has been a member of the NIAID-funded Atopic Dermatitis Research Network (ADRN) since its inception in 1993. She has chaired numerous multicenter clinical and mechanistic studies, including a large AD registry, skin barrier investigations, and studies examining dupilumab's effects on host–microbial interactions. She has published over
Upcoming
American Academy of Dermatology Annual Meeting 2027 19 March 2027 – 23 March 2027
- Atopic Dermatitis Speaker · 21 March 2027
Spoke alongside
People who have shared a session with Lisa at events on B2DB.
- Aaron Mark Drucker, MD, FAAD University of Toronto 1 shared session
- Amy S. Paller, MD, FAAD Northwestern University 1 shared session
- Brian S. Kim, MD, FAAD 1 shared session
- Lawrence F. Eichenfield, MD, FAAD University of California San Diego and Rady Children's Hospital 1 shared session